Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis.
El-Shabrawi
Y
Y
Hermann
J
J
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002908:Chronic Disease; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D015423:Scleritis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab